These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Extrapyramidal side effects of psychotropic drugs. Greenblatt DJ; Shader RI; DiMascio A Conn Med; 1969 Mar; 33(3):197-201. PubMed ID: 5773504 [No Abstract] [Full Text] [Related]
26. [Persistent extrapyramidal syndrome in neuroleptic therapy]. Hoff H; Hofmann G Wien Med Wochenschr; 1967 Jan; 117(1):14-7. PubMed ID: 6031954 [No Abstract] [Full Text] [Related]
27. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment]. Haddenbrock S Nervenarzt; 1966 May; 37(5):199-203. PubMed ID: 5298253 [No Abstract] [Full Text] [Related]
30. [Drug induced functional disorders of the tongue, pharynx and larynx]. Bauer H Z Laryngol Rhinol Otol; 1967 Mar; 46(3):154-9. PubMed ID: 4870673 [No Abstract] [Full Text] [Related]
31. [Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)]. Korn M; Pinchard A; Breulet M; Goffioul F; Bobon J Acta Psychiatr Belg; 1971 Mar; 71(2):65-75. PubMed ID: 5560276 [No Abstract] [Full Text] [Related]
32. [The neuroleptic syndrome]. Ostaptzeff G; Ostaptzeff-Lavoine M Ann Med Psychol (Paris); 1970 Nov; 2(4):614-7. PubMed ID: 5503374 [No Abstract] [Full Text] [Related]
33. [On the problem of fixed extrapyramidal disorders following prolonged use of neuroleptics]. Krystof J; Kajzer J Psychiatr Pol; 1967; 1(3):289-93. PubMed ID: 5593256 [No Abstract] [Full Text] [Related]
34. [Late dyskinesia caused by neuroleptics. Survey on 1,660 psychiatric hospital patients]. Bourgeois M; Graux C; Arrethche-Berthelot N Ann Med Psychol (Paris); 1976 May; 1(5):737-46. PubMed ID: 970829 [TBL] [Abstract][Full Text] [Related]
35. [Symptoms of the extrapyramidal syndrome during maintenence therapy with neuroleptic drugs]. Sujecka-Szymkiewicz H Psychiatr Pol; 1967; 1(1):79-84. PubMed ID: 4876412 [No Abstract] [Full Text] [Related]
37. Predictors of therapeutic responsivity to thiothixene in schizophrenics. Sterlin C; Oliveros R; Ban TA Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):394-6. PubMed ID: 4882603 [No Abstract] [Full Text] [Related]
38. [Re-examination of long-term drug therapy in mental diseases with special reference to its non-reversible side effects]. Kazamatsuri H Seishin Shinkeigaku Zasshi; 1974 Oct; 76(10):663-7. PubMed ID: 4157044 [No Abstract] [Full Text] [Related]
39. [Movement disorders as a concomitant syndrome in the use of psychopharmacological agents]. von der Mühlen H Z Allgemeinmed; 1973 Oct; 49(30):1441-7. PubMed ID: 4768492 [No Abstract] [Full Text] [Related]
40. [Clinical study of amantadine in extrapyramidal syndromes caused by neuroleptics]. Nardini M; Fanali A; Sorgonà F; Vergnano M; Fieschi G Minerva Med; 1971 Oct; 62(82):4020-3. PubMed ID: 5125070 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]